BioSpace News Archive

UnitedHealth Group will release its first quarter 2020 financial results on Wednesday, April 15, 2020, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors.

Randomizations concluded and trial participation in process of concluding to ensure patient safety during COVID-19 pandemic

Navidea Biopharmaceuticals, Inc. announced that on March 17, 2020 the U.S. Patent and Trademark Office issued a Certificate to extend the duration of U.S. patent 6,409,990 for an additional five years through May 12, 2025.

All of the Tauri-Gum™ Flavors (Mint, Blood Orange, Pomegranate) will be Available at Each of the 5 Erewhon Market Locations (Calabasas, Santa Monica, Venice, Pacific Palisades, and Los Angeles) LOS ANGELES, CALIFORNIA, March 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potenti

Ocugen, Inc. today announced that it will release its 2019 financial results and provide a business update before the open of the U.S. financial markets on Friday, March 27, 2020. The company will host a conference call at 8:30 a.m. ET on the same day to discuss the resul

Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative cell therapies for solid tumors, today announced it has entered into a common stock purchase agreement for up to $25 million with Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional investor. Under the terms of the purchase agreement, Unum Therapeutics will have the sole discretion, but not the obligation, to direct LPC to pu

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN), today provided an update on the impact of the global outbreak of COVID-19 on its business operations.

Daxor Corporation today announced the first use of its BVA-100 test to guide volume treatment in a patient infected with the COVID-19 virus. The company also announced the release of a clinical protocol for fluid guidance when ut

Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, issued a response today to the ongoing COVID-19 impact, reassuring its valued customers, shareholders, and partners that business will continue as usual. The company has taken steps to ensure that its customers have continued access to an increased supply of Bioflux® units as demand for remote patient monitoring grows during this ti

Samsung Biologics (207940.KS) announced the appointment and expansion of its board of directors at its 9 th annual general meeting of shareholders that took place on March 20 th . In the course of expanding its business model from a contract manufacturing (CMO) company to development (CDO) and research (CRO) services, Samsung